Friday
SESSION 31: MORE ON THORACIC AND ABDOMINAL ANEURYSMS AND THEIR MANAGEMENT (5-MINUTE TALKS - OTHER RELATED TOPICS ARE IN SESSIONS 25, 28, 30 AND 37)
Moderators:Christoph A. Nienaber, MD, PhD / Michael L. Marin, MD  
SESSION 31 SCHEDULE
PROGRAM E (SESSIONS 31 - 32) - LOCATION: GRAND BALLROOM EAST, 3RD FLOOR
1:00 PM - 1:05 PM What Improvements Are Occurring With Thoracic Endografts And How Are They Helping In Patient Treatment
  Presenter(s):Ronald M. Fairman, MD  
1:06 PM - 1:11 PM Results Of The North American Complex Abdominal Aortic Debranching Registry (NACAADR): How Good/Bad Are The Results Of Visceral/Renal Debranching Nationwide
  Presenter(s):Gustavo S. Oderich, MD  
1:12 PM - 1:17 PM Tips And Tricks For Performing Abdominal Debranching Safely And Effectively With Low Morbidity And Mortality
  Presenter(s):William J. Quinones-Baldrich, MD  
1:18 PM - 1:23 PM What Improvements Have Occurred With AAA EVAR Devices And How Are They Helping In Patient Treatment
  Presenter(s):Michel S. Makaroun, MD  
1:24 PM - 1:29 PM Non-Surgical Treatment Of Intraabdominal Hypertension In Abdominal Compartment Syndrome (ACS): What Are The Techniques And When Is It Safe And When Not
  Presenter(s):Martin Bjorck, MD, PhD  
1:30 PM - 1:35 PM Late Type I Endoleaks After EVAR: How Dangerous/Safe Is Conservative Treatment: When Can They Be Treated By Coils And Glue
  Presenter(s):James May, MD, MS, FRACS, FACS  
1:36 PM - 1:41 PM How Can You Predict Which EVAR Patient Will Get A Persistent And Problematic Type II Endoleak? What Should Be Done About It
  Presenter(s):Glenn M. LaMuraglia, MD  
1:42 PM - 1:47 PM DEBATE: Use Of Non-Onyx Glue In The Treatment Of Persistent Type II Endoleaks: Technical Tips And Results: You Don’t Need Onyx
  Presenter(s):Neal S. Cayne, MD  
1:48 PM - 1:53 PM DEBATE: Onyx (“Glue”) In The Treatment Of Persistent Type II Endoleaks: Technical Tips And Onyx Is Best
  Presenter(s):Christopher J. Kwolek, MD  
1:54 PM - 1:59 PM Treatment Of Type I Endoleaks After EVAR With Fibrin Glue Embolization
  Presenter(s):Zaiping Jing, MD  
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 31
previous next